Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 51,778 | 38,961 | 28,814 | 24,131 | 15,290 |
| Operating Income | -51,778 | -38,961 | -28,814 | -24,131 | -15,290 |
| Other Income | 7,262 | -3,870 | -3,039 | 9 | 196 |
| Pre-tax Income | -44,516 | -42,831 | -31,853 | -24,122 | -15,094 |
| Income Tax | 66 | -60 | -60 | N/A | N/A |
| Net Income Continuous | -44,582 | -42,771 | -31,793 | -24,122 | -15,094 |
| Net Income | $-44,582 | $-42,771 | $-31,793 | $-24,122 | $-15,094 |
| EPS Basic Total Ops | -36.64 | -105.11 | -135.44 | -130.63 | -228.23 |
| EPS Basic Continuous Ops | -36.56 | -105.09 | -135.31 | -130.48 | -228.78 |
| EPS Diluted Total Ops | -42.04 | -105.11 | -135.44 | -130.63 | -228.23 |
| EPS Diluted Continuous Ops | -36.04 | -105.09 | -135.31 | -130.48 | -228.78 |
| EPS Diluted Before Non-Recurring Items | -46.55 | -94.60 | -121.62 | -129.13 | -228.23 |
| EBITDA(a) | $-51,486 | $-38,768 | $-28,665 | $-23,981 | $-15,149 |